Grants Search Results

This grant supports a nurse educator for the Adolescent and Young Adult (AYA) program at this institution to improve patient outcomes and care.

This grant funds research personnel to ensure that more kids can be treated on clinical trials, often their best hope for a cure.

This grant supports a Clinical Research Associate to ensure that more kids can be treated on clinical trials, often their best hope for a cure.

This grant helps provide necessary resources to help establish Nevada's first Pediatric Brain Tumor Program.

This grant supports an adolescent-young Adult (AYA) liaison to ensure that more AYAs can be treated on clinical trials, often their best hope for a cure.

This grant helps provide necessary resources for the Childhood Cancer Survivorship Program at this institution. The program provides survivors the support, treatment and education they need to prevent and address these late effects.

This grant supports a Clinical Research Associate to ensure that more kids can be treated on clinical trials, often their best hope for a cure.

This grant funds personnel to ensure that more kids can be treated on clinical trials, often their best hope for a cure.

This grant funds a Clinical Research Associate to ensure that more kids can be treated on clinical trials, often their best hope for a cure.

This grant funds a clinical research coordinator to ensure that more kids can be treated on clinical trials, often their best hope for a cure.

This grant supports a Clinical Research Associate to ensure that more kids can be treated on clinical trials, often their best hope for a cure.

This grant funds a Clinical Research Nurse to ensure that more kids can be treated on clinical trials, often their best hope for a cure.

This grant supports a Clinical Research Associate to ensure that more kids can be treated on clinical trials, often their best hope for a cure.

Funding from the St. Baldrick's Foundation has taken two very small programs at UIC and Rush Medical Centers, merged them and brought Stroger Medical Center into the fold to forge a single entity for purposes of participation in Children's Oncology Group clinical trials. This support of necessary personnel has significantly increased clinical trial participation for patients who otherwise might not have access to them.

This grant supportss a Clinical Research Coordinator to ensure that more kids can be treated on clinical trials, often their best hope for a cure.

This grant supports a Clinical Research Associate dedicated to Phase I, II, and III brain tumor clinical trials, to ensure that more kids can be treated on clinical trials.

This grant funds a pediatric specific pharmacist at this institution to improve patient outcomes and care.

Genetic studies have identified the molecular causes of childhood cancers such as T-cell leukemia and neuroblastoma. A recurrent theme in these cancers is abnormal activation of the MYC gene. Accordingly, researchers like Dr. Wendel have spent much time and effort in trying to identify inhibitors of MYC as they believe these could be very powerful therapies for these childhood cancers. Dr. Wendel and his colleagues recently found a new way to block the production of MYC using a natural compound. The natural product is rare and hard to come by and therefore Dr. Wendel and his colleagues are exploring ways to generate synthetic drugs based on this plant product. With support from the St. Baldrick’s Foundation they are working to bring this new strategy to the clinic. They focus especially on heavily pre-treated and relapsed childhood leukemia because affected children have few options and they hope to make a difference.

Neuroblastoma is a cancer of the cells that become nerve tissues in the body, except in the brain. Dr. Bernstein is studying the effect of a particular mutation in neuroblastoma – an event that alters the DNA sequence to promote cancer. This mutation lies in a gene called ATRX. Dr. Bernstein takes a genomics approach to understand how ATRX mutations promote neuroblastoma in order to discover new therapies for children with ATRX mutations.

Based on progress to date, Dr. Bhakta was awarded a new grant in 2017 to fund an additional year of this Fellow award. While the increase cure rates for many childhood cancers is cause for celebration, researchers are increasingly recognizing the long-term consequences of cancer therapy. Recent studies have shown that survivors of childhood cancer are at risk for developing a wide range of long-term health problems and die at an earlier age due to the lifelong side effects of their curative therapies. Dr. Bhakta is investigating the magnitude of chronic health conditions experienced by survivors to inform future approaches for prevention and early detection to maximize long-term survival and quality of life.

A portion of the grant was generously supported by the Morgan and Friends Fund created to honor Morgan Loudon and celebrate her strength and determination as a cancer survivor while rallying family and friends to "battle on" in the search for cures and better treatments.